1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Candidiasis Global Clinical Trials Review, H1, 2015

Candidiasis Global Clinical Trials Review, H1, 2015

  • June 2015
  • -
  • Global Data
  • -
  • 101 pages

Candidiasis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H1, 2015" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Candidiasis Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Candidiasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Candidiasis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Candidiasis Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Astellas Pharma Inc. 37
Clinical Trial Overview of Astellas Pharma Inc. 37
Merck and Co., Inc. 39
Clinical Trial Overview of Merck and Co., Inc. 39
Basilea Pharmaceutica AG 41
Clinical Trial Overview of Basilea Pharmaceutica AG 41
Johnson and Johnson 42
Clinical Trial Overview of Johnson and Johnson 42
Bayer AG 43
Clinical Trial Overview of Bayer AG 43
Laboratory Corporation of America Holdings 44
Clinical Trial Overview of Laboratory Corporation of America Holdings 44
GlaxoSmithKline Plc 45
Clinical Trial Overview of GlaxoSmithKline Plc 45
Durata Therapeutics, Inc. 46
Clinical Trial Overview of Durata Therapeutics, Inc. 46
Bristol-Myers Squibb Company 47
Clinical Trial Overview of Bristol-Myers Squibb Company 47
Clinical Trial Overview of Top Institutes / Government 48
The National Institute of Allergy and Infectious Diseases 48
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 48
National Cancer Institute 49
Clinical Trial Overview of National Cancer Institute 49
Duke University 50
Clinical Trial Overview of Duke University 50
University Medical Center Groningen 51
Clinical Trial Overview of University Medical Center Groningen 51
Ahvaz Jundishapur University of Medical Sciences 52
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 52
Indian Council of Medical Research 53
Clinical Trial Overview of Indian Council of Medical Research 53
Shahid Beheshti University 54
Clinical Trial Overview of Shahid Beheshti University 54
Shiraz University of Medical Sciences 55
Clinical Trial Overview of Shiraz University of Medical Sciences 55
Tehran University of Medical Sciences 56
Clinical Trial Overview of Tehran University of Medical Sciences 56
The University of Melbourne 57
Clinical Trial Overview of The University of Melbourne 57
Five Key Clinical Profiles 58
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101

List of Tables
Candidiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Candidiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Candidiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Candidiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Candidiasis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Candidiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Candidiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 37
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 39
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2015* 41
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 42
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 43
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratory Corporation of America Holdings, 2015* 44
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 45
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Durata Therapeutics, Inc., 2015* 46
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 47
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 48
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 49
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 50
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 51
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2015* 52
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2015* 53
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2015* 54
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 55
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 56
Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Melbourne, 2015* 57

List of Figures
Candidiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Candidiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Candidiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Candidiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 99

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Multiparameter Patient Monitoring - Pipeline Review, 2015

Multiparameter Patient Monitoring - Pipeline Review, 2015

  • $ 4 000
  • Industry report
  • May 2015
  • by Global Data

Multiparameter Patient Monitoring - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Multiparameter Patient Monitoring - Pipeline Review, 2015" provides an overview of Multiparamete ...

Artificial Pancreas - Pipeline Review, 2015

Artificial Pancreas - Pipeline Review, 2015

  • $ 4 000
  • Industry report
  • June 2015
  • by Global Data

Artificial Pancreas - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Artificial Pancreas - Pipeline Review, 2015" provides an overview of Artificial Pancreas currently in ...

Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025

Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025

  • $ 2 676
  • Industry report
  • June 2015
  • by Visiongain

Report Details Clinical Trials – Discover Commercial Potentials of Outsourced Drug Testing, Benefiting Your Authority What does the future hold for pharmaceutical clinical research providers? Visiongain’s ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.